BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35704854)

  • 1. Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine.
    Eckshtain-Levi M; Batty CJ; Lifshits LM; McCammitt B; Moore KM; Amouzougan EA; Stiepel RT; Duggan E; Ross TM; Bachelder EM; Ainslie KM
    ACS Appl Mater Interfaces; 2022 Jun; 14(25):28548-28558. PubMed ID: 35704854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.
    Hendy DA; Lifshits LM; Batty CJ; Carlock MA; Ross TM; Mousa JJ; Bachelder EM; Ainslie KM
    Mol Pharm; 2023 Sep; 20(9):4687-4697. PubMed ID: 37603310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan.
    Roque JA; Lukesh NR; Hendy DA; Dixon TA; Islam MJ; Ontiveros-Padilla L; Pena ES; Lifshits LM; Simpson SR; Batty CJ; Bachelder EM; Ainslie KM
    Int J Pharm; 2024 May; 656():124076. PubMed ID: 38569976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained delivery of CpG oligodeoxynucleotide by acetalated dextran microparticles augments effector response to Computationally Optimized Broadly Reactive Antigen (COBRA) influenza hemagglutinin.
    Batty CJ; Amouzougan EA; A Carlock M; Ross TM; Bachelder EM; Ainslie KM
    Int J Pharm; 2023 Jan; 630():122429. PubMed ID: 36436743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    Allen JD; Ross TM
    J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    Sautto GA; Kirchenbaum GA; Abreu RB; Ecker JW; Pierce SR; Kleanthous H; Ross TM
    J Immunol; 2020 Jan; 204(2):375-385. PubMed ID: 31811019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 14. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.
    Giles BM; Ross TM
    Vaccine; 2011 Apr; 29(16):3043-54. PubMed ID: 21320540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-Mediated Assembly of Vaccine Particles to Improve Stability and Immunogenicity.
    Zhang G; Fu X; Sun H; Zhang P; Zhai S; Hao J; Cui J; Hu M
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):13978-13989. PubMed ID: 33749241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
    Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guest-adaptable and water-stable peptide-based porous materials by imidazolate side chain control.
    Katsoulidis AP; Park KS; Antypov D; Martí-Gastaldo C; Miller GJ; Warren JE; Robertson CM; Blanc F; Darling GR; Berry NG; Purton JA; Adams DJ; Rosseinsky MJ
    Angew Chem Int Ed Engl; 2014 Jan; 53(1):193-8. PubMed ID: 24302659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scalable synthesis of adjuvanting antigen depots based on metal-organic frameworks.
    Ehrman RN; Brohlin OR; Wijesundara YH; Kumari S; Trashi O; Howlett TS; Trashi I; Herbert FC; Raja A; Koirala S; Tran N; Al-Kharji NM; Tang W; Senarathna MC; Hagge LM; Smaldone RA; Gassensmith JJ
    Chem Sci; 2024 Feb; 15(8):2731-2744. PubMed ID: 38404371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.